Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?

by Zacks Equity Research Published on July 16,2019

Sector ETF report for PBE

• PBE Quick QuotePBENegative Net Change
• IBB Quick QuoteIBBNegative Net Change
• XBI Quick QuoteXBIPositive Net Change
• TECH Quick QuoteTECHPositive Net Change
• INCY Quick QuoteINCYNegative Net Change
• AMGN Quick QuoteAMGNNegative Net Change

• dividend
• etf
• expenses
• holdings
• index
• us-equities

Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?

by Sweta Killa Published on June 21,2019

Sector ETF report for PBE

• PBE Quick QuotePBENegative Net Change
• IBB Quick QuoteIBBNegative Net Change
• XBI Quick QuoteXBIPositive Net Change
• TECH Quick QuoteTECHPositive Net Change
• CELG Quick QuoteCELGPositive Net Change
• AMGN Quick QuoteAMGNNegative Net Change

• dividend
• etf
• expenses
• holdings
• index
• us-equities

Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?

by Zacks Equity Research Published on May 30,2019

Sector ETF report for PBE

• PBE Quick QuotePBENegative Net Change
• IBB Quick QuoteIBBNegative Net Change
• XBI Quick QuoteXBIPositive Net Change
• QGEN Quick QuoteQGENNegative Net Change
• CELG Quick QuoteCELGPositive Net Change
• ILMN Quick QuoteILMNPositive Net Change

• alt-energy
• dividend
• energy
• etf
• expenses
• holdings
• index
• tech-stocks
• us-equities

Biotech ETFs in Focus on String of Q1 Earnings Beats

by Sweta Jaiswal, FRM Published on May 07,2019

Let's take a sneak peek at some ETFs having high exposure to some impactful biotechnological companies on the release of Q1 earnings results.

• FBT Quick QuoteFBTNegative Net Change
• BBH Quick QuoteBBHNegative Net Change
• IBB Quick QuoteIBBNegative Net Change
• BIB Quick QuoteBIBNegative Net Change
• BIIB Quick QuoteBIIBPositive Net Change
• AMGN Quick QuoteAMGNNegative Net Change
• ALXN Quick QuoteALXNPositive Net Change
• GILD Quick QuoteGILDNegative Net Change

• etfs

Will Biotech ETFs Continue to Rally in Q1 Earnings?

by Sweta Jaiswal, FRM Published on April 24,2019

Here we study the possible impact of some major Q1 earnings releases on certain biotech ETFs .

• FBT Quick QuoteFBTNegative Net Change
• BBH Quick QuoteBBHNegative Net Change
• BIB Quick QuoteBIBNegative Net Change
• IBB Quick QuoteIBBNegative Net Change
• GILD Quick QuoteGILDNegative Net Change
• ALXN Quick QuoteALXNPositive Net Change
• AMGN Quick QuoteAMGNNegative Net Change

• biotechs
• earnings
• etfs

Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?

by Zacks Equity Research Published on April 12,2019

Sector ETF report for PBE

• PBE Quick QuotePBENegative Net Change
• IBB Quick QuoteIBBNegative Net Change
• XBI Quick QuoteXBIPositive Net Change
• CELG Quick QuoteCELGPositive Net Change
• ILMN Quick QuoteILMNPositive Net Change
• ALNY Quick QuoteALNYNegative Net Change

• dividend
• etf
• expenses
• holdings
• index
• tech-stocks
• us-equities

Global X Launches GNOM ETF to Tap Booming Genomics Space

by Sweta Jaiswal, FRM Published on April 10,2019

Having exposure to trending areas like Robotics & AI, e-commerce and IoT, Global X is set to gain from the booming genomics market with the GNOM ETF.

• IBB Quick QuoteIBBNegative Net Change
• PBE Quick QuotePBENegative Net Change
• RARE Quick QuoteRAREPositive Net Change
• ILMN Quick QuoteILMNPositive Net Change
• ARKG Quick QuoteARKGNegative Net Change

• biotechs
• etfs
• pharmaceuticals

Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?

by Zacks Equity Research Published on March 20,2019

Sector ETF report for PBE

• PBE Quick QuotePBENegative Net Change
• IBB Quick QuoteIBBNegative Net Change
• XBI Quick QuoteXBIPositive Net Change
• REGN Quick QuoteREGNPositive Net Change
• QGEN Quick QuoteQGENNegative Net Change
• ALNY Quick QuoteALNYNegative Net Change

• dividend
• etf
• expenses
• holdings
• index
• tech-stocks
• us-equities

Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?

by Sweta Killa Published on February 20,2019

Sector ETF report for PBE

• PBE Quick QuotePBENegative Net Change
• IBB Quick QuoteIBBNegative Net Change
• XBI Quick QuoteXBIPositive Net Change
• VRTX Quick QuoteVRTXNegative Net Change
• QGEN Quick QuoteQGENNegative Net Change
• REGN Quick QuoteREGNPositive Net Change

• dividend
• etf
• expenses
• holdings
• index
• tech-stocks
• us-equities

Despite M&A Spree, Biotech ETFs Slide on Mixed Earnings

by Sanghamitra Saha Published on February 14,2019

Biotech stocks came up with mixed earnings and weighed on the related ETFs in the key reporting season.

• FBT Quick QuoteFBTNegative Net Change
• IBB Quick QuoteIBBNegative Net Change
• BBH Quick QuoteBBHNegative Net Change
• BIIB Quick QuoteBIIBPositive Net Change
• GILD Quick QuoteGILDNegative Net Change
• AMGN Quick QuoteAMGNNegative Net Change
• ALXN Quick QuoteALXNPositive Net Change

• biotechs
• etfs

What's Behind the Biotech ETF Rally to Start 2019?

by Sanghamitra Saha Published on January 24,2019

Biotech ETFs have been riding on the wave of mergers and acquisitions as well as drug approvals.

• AZN Quick QuoteAZNNegative Net Change
• LLY Quick QuoteLLYNegative Net Change
• GSK Quick QuoteGSKNegative Net Change
• ABBV Quick QuoteABBVPositive Net Change
• BMY Quick QuoteBMYNegative Net Change
• BBH Quick QuoteBBHNegative Net Change
• FBT Quick QuoteFBTNegative Net Change
• BTEC Quick QuoteBTECPositive Net Change
• IBB Quick QuoteIBBNegative Net Change
• BBP Quick QuoteBBPPositive Net Change
• IVV Quick QuoteIVVNegative Net Change
• BIIB Quick QuoteBIIBPositive Net Change
• GILD Quick QuoteGILDNegative Net Change
• CLVS Quick QuoteCLVSPositive Net Change

• biotechs
• etfs

Bristol-Myers to Acquire Celgene: Healthcare ETFs in Focus

by Sweta Killa Published on January 04,2019

The news has put the spotlight on a number of healthcare ETFs, especially biotech and pharma, which could be the best ways for investors to tap the opportunity arising from the BMY-CELG deal.

• BMY Quick QuoteBMYNegative Net Change
• IBB Quick QuoteIBBNegative Net Change
• BBH Quick QuoteBBHNegative Net Change
• IHE Quick QuoteIHENegative Net Change
• PJP Quick QuotePJPNegative Net Change
• CELG Quick QuoteCELGPositive Net Change
• IEIH Quick QuoteIEIHPositive Net Change

• biotechs
• etfs
• pharmaceuticals

Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?

by Sweta Killa Published on January 04,2019

Sector ETF report for PBE

• PBE Quick QuotePBENegative Net Change
• IBB Quick QuoteIBBNegative Net Change
• XBI Quick QuoteXBIPositive Net Change
• GILD Quick QuoteGILDNegative Net Change
• QGEN Quick QuoteQGENNegative Net Change
• REGN Quick QuoteREGNPositive Net Change

• dividend
• etf
• expenses
• holdings
• index
• tech-stocks
• us-equities

Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?

by Zacks Equity Research Published on December 13,2018

Sector ETF report for PBE

• PBE Quick QuotePBENegative Net Change
• IBB Quick QuoteIBBNegative Net Change
• XBI Quick QuoteXBIPositive Net Change
• ILMN Quick QuoteILMNPositive Net Change
• VRTX Quick QuoteVRTXNegative Net Change
• AMGN Quick QuoteAMGNNegative Net Change

• dividend
• etf
• expenses
• holdings
• index
• tech-stocks
• us-equities

The Zacks Analyst Blog Highlights: Gilead Sciences, Alexion Pharmaceuticals, Regeneron Pharmaceutical and Biogen

by Zacks Equity Research Published on December 12,2018

The Zacks Analyst Blog Highlights: Gilead Sciences, Alexion Pharmaceuticals, Regeneron Pharmaceutical and Biogen

• IBB Quick QuoteIBBNegative Net Change
• REGN Quick QuoteREGNPositive Net Change
• GILD Quick QuoteGILDNegative Net Change
• ALXN Quick QuoteALXNPositive Net Change
• BIIB Quick QuoteBIIBPositive Net Change

• medical

Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?

by Sweta Killa Published on November 21,2018

Sector ETF report for PBE

• PBE Quick QuotePBENegative Net Change
• IBB Quick QuoteIBBNegative Net Change
• XBI Quick QuoteXBIPositive Net Change
• BIIB Quick QuoteBIIBPositive Net Change
• VRTX Quick QuoteVRTXNegative Net Change
• AMGN Quick QuoteAMGNNegative Net Change

• dividend
• etf
• expenses
• holdings
• index
• tech-stocks
• us-equities

Biotech ETFs in Focus on String of Q3 Earnings Beat

by Zacks Equity Research Published on November 01,2018

Biotech ETFs draw attention post impressive Q3 results.

• BBH Quick QuoteBBHNegative Net Change
• IBB Quick QuoteIBBNegative Net Change
• FBT Quick QuoteFBTNegative Net Change
• ALXN Quick QuoteALXNPositive Net Change
• AMGN Quick QuoteAMGNNegative Net Change
• BIIB Quick QuoteBIIBPositive Net Change
• GILD Quick QuoteGILDNegative Net Change

• etfs

Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?

by Zacks Equity Research Published on October 30,2018

Sector ETF report for PBE

• PBE Quick QuotePBENegative Net Change
• IBB Quick QuoteIBBNegative Net Change
• XBI Quick QuoteXBIPositive Net Change
• VRTX Quick QuoteVRTXNegative Net Change
• REGN Quick QuoteREGNPositive Net Change
• AMGN Quick QuoteAMGNNegative Net Change

• dividend
• etf
• expenses
• holdings
• index
• tech-stocks
• us-equities

Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?

by Zacks Equity Research Published on October 08,2018

Sector ETF report for PBE

• PBE Quick QuotePBENegative Net Change
• IBB Quick QuoteIBBNegative Net Change
• XBI Quick QuoteXBIPositive Net Change
• ILMN Quick QuoteILMNPositive Net Change
• VRTX Quick QuoteVRTXNegative Net Change
• AMGN Quick QuoteAMGNNegative Net Change

• dividend
• etf
• expenses
• holdings
• index
• us-equities

Health Care ETFs Outperforming: Will the Rally Last?

by Sanghamitra Saha Published on August 13,2018

Health care ETFs are defensive ones, which helped those to shine amid market doldrums.

• XLP Quick QuoteXLPPositive Net Change
• XLV Quick QuoteXLVNegative Net Change
• XLU Quick QuoteXLUNegative Net Change
• IBB Quick QuoteIBBNegative Net Change
• XLY Quick QuoteXLYPositive Net Change
• IHI Quick QuoteIHINegative Net Change
• XPH Quick QuoteXPHNegative Net Change

Biotech ETFs in Focus on String of Q2 Earnings Beat

by Sanghamitra Saha Published on August 10,2018

Biotech ETFs draw attention post impressive Q2 results.

• IBB Quick QuoteIBBNegative Net Change
• FBT Quick QuoteFBTNegative Net Change
• BBH Quick QuoteBBHNegative Net Change
• ALXN Quick QuoteALXNPositive Net Change
• GILD Quick QuoteGILDNegative Net Change
• AMGN Quick QuoteAMGNNegative Net Change
• BIIB Quick QuoteBIIBPositive Net Change
• IEIH Quick QuoteIEIHPositive Net Change

What Investors Need to Know about Biotech ETFs

by Neena Mishra Published on July 12,2018

Smaller biotech stocks are outperforming this year; learn more about biotech ETFs best positioned to benefit

• IBB Quick QuoteIBBNegative Net Change
• FBT Quick QuoteFBTNegative Net Change
• XBI Quick QuoteXBIPositive Net Change

Biotech ETFs Surge on Biogen's Positive Drug Trial Result

by Sweta Killa Published on July 09,2018

Biotech ETFs surge on Biogen's encouraging Phase 2 clinical study data for Alzheimer???s treatment.

• IBB Quick QuoteIBBNegative Net Change
• FBT Quick QuoteFBTNegative Net Change
• PBE Quick QuotePBENegative Net Change
• BBH Quick QuoteBBHNegative Net Change
• GILD Quick QuoteGILDNegative Net Change
• CELG Quick QuoteCELGPositive Net Change
• AMGN Quick QuoteAMGNNegative Net Change
• BIIB Quick QuoteBIIBPositive Net Change

Why Biotech Stocks Rallied on Biogen's Alzheimer's Test

by Ryan McQueeney Published on July 06,2018

Several major biotech stocks rallied on Friday after Biogen (BIIB) reported positive results from a Phase 2 study of its Ban2401 therapy, which seeks to reduce toxic amyloid proteins associated with cognitive decline and Alzheimer's disease.

• IBB Quick QuoteIBBNegative Net Change
• GILD Quick QuoteGILDNegative Net Change
• CELG Quick QuoteCELGPositive Net Change
• AMGN Quick QuoteAMGNNegative Net Change
• BIIB Quick QuoteBIIBPositive Net Change
• ESALY Quick QuoteESALYPositive Net Change

Sarepta Pharma Pushes Two Biotech ETFs to New Highs

by Sweta Killa Published on June 20,2018

The encouraging early trial results for a gene therapy for Duchenne muscular dystrophy pushed Sarepta Therapeutics and few biotech ETFs to new highs.

• IBB Quick QuoteIBBNegative Net Change
• BBC Quick QuoteBBCPositive Net Change
• BBP Quick QuoteBBPPositive Net Change
• XBI Quick QuoteXBIPositive Net Change
• SBIO Quick QuoteSBIOPositive Net Change
• ALXN Quick QuoteALXNPositive Net Change
• VRTX Quick QuoteVRTXNegative Net Change
• ALNY Quick QuoteALNYNegative Net Change
• BIIB Quick QuoteBIIBPositive Net Change
• SRPT Quick QuoteSRPTPositive Net Change
• SLDB Quick QuoteSLDBNegative Net Change